Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma
Clinical trial NCT00803374 · WITHDRAWN
Trial details
- NCT number
- NCT00803374
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.